Ranked #1,655 of 8,699 institutional investors
Rock Springs Capital Management LP
Baltimore, MD
$1.72B
US stock portfolio at live prices · today −$11.2M (−0.65%)
Live prices, last trade 12:16 PM ET
- Value at quarter end (Q3 2026)
- $1.86B
- Change from Q2 2026
- −$188.9M (−9.22%)
- Positions
- 100 · 11 new, 7 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$83.2M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesRVMD 8.14%LLY 7.78%TVTX 6.19%RYTM 4.54%MIRM 4.44%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. | 869,256 | $140M | 8.14% | Reduced −21% |
| LLY Eli Lilly and Company | 98,700 | $134M | 7.78% | Unchanged |
| TVTX Travere Therapeutics, Inc. | 2,204,085 | $106M | 6.19% | Added +1% |
| RYTM Rhythm Pharmaceuticals, Inc. | 692,598 | $78.0M | 4.54% | Unchanged |
| MIRM Mirum Pharmaceuticals, Inc. | 779,790 | $76.2M | 4.44% | Reduced −2% |
| MDGL Madrigal Pharmaceuticals, Inc. | 177,249 | $68.8M | 4.00% | Added +1% |
| INSM Insmed Incorporated | 365,250 | $53.4M | 3.11% | Added +1% |
| KYMR Kymera Therapeutics, Inc. | 409,631 | $47.5M | 2.76% | Reduced −10% |
| SRRK Scholar Rock Holding Corporation | 682,654 | $34.4M | 2.00% | Reduced −5% |
| THC Tenet Healthcare Corporation | 125,000 | $32.9M | 1.91% | Unchanged |
| UNH UnitedHealth Group Incorporated | 92,250 | $31.8M | 1.85% | Added +45% |
| ISRG Intuitive Surgical, Inc. | 72,250 | $29.3M | 1.71% | Reduced −6% |
| ARGX argenx SE | 30,000 | $28.2M | 1.64% | Reduced −43% |
| HTFL Heartflow, Inc. | 575,000 | $26.5M | 1.54% | Added +0% |
| MMED MiniMed Group, Inc. | 1,605,000 | $26.0M | 1.52% | Added +6% |
| IRTC iRhythm Holdings, Inc. | 273,950 | $25.9M | 1.51% | Added +2% |
| DXCM DexCom, Inc. | 293,500 | $23.3M | 1.36% | Reduced −14% |
| AGL agilon health, inc. | 262,500 | $23.3M | 1.36% | Unchanged |
| BSX Boston Scientific Corporation | 535,000 | $22.9M | 1.33% | Added +1% |
| COAG Hemab Therapeutics Holdings, Inc. | 575,432 | $22.7M | 1.32% | Unchanged |
| TARS Tarsus Pharmaceuticals, Inc. | 285,122 | $21.3M | 1.24% | Added +3% |
| NBIX Neurocrine Biosciences, Inc. | 130,500 | $19.9M | 1.16% | Reduced −10% |
| ERAS Erasca, Inc. | 1,405,393 | $19.8M | 1.15% | Added +0% |
| AMLX Amylyx Pharmaceuticals, Inc. | 756,774 | $19.6M | 1.14% | Added +51% |
| XENE Xenon Pharmaceuticals Inc. | 524,758 | $19.6M | 1.14% | Reduced −23% |
| PEN Penumbra, Inc. | 60,000 | $19.2M | 1.12% | Reduced −48% |
| AVLN Avalyn Pharma Inc. | 662,918 | $18.9M | 1.10% | Unchanged |
| ELVN Enliven Therapeutics, Inc. | 393,659 | $18.1M | 1.05% | Reduced −15% |
| CLDX Celldex Therapeutics, Inc. | 653,344 | $17.9M | 1.04% | Reduced −7% |
| DHR Danaher Corporation | 76,300 | $17.0M | 0.99% | Unchanged |
| ZLAB Zai Lab Limited | 791,307 | $16.3M | 0.95% | Reduced −3% |
| PBLS Parabilis Medicines, Inc. | 577,281 | $16.1M | 0.93% | Reduced −0% |
| RARE Ultragenyx Pharmaceutical Inc. | 925,089 | $15.3M | 0.89% | Reduced −4% |
| BBIO BridgeBio Pharma, Inc. | 192,250 | $14.9M | 0.86% | Added +33% |
| MBX MBX Biosciences, Inc. | 275,347 | $14.1M | 0.82% | Reduced −8% |
| DYN Dyne Therapeutics, Inc. | 891,869 | $14.1M | 0.82% | Reduced −5% |
| INSP Inspire Medical Systems, Inc. | 244,000 | $13.5M | 0.79% | Unchanged |
| AGIO Agios Pharmaceuticals, Inc. | 472,335 | $13.4M | 0.78% | Reduced −11% |
| ACRS Aclaris Therapeutics, Inc. | 3,791,117 | $13.1M | 0.76% | Reduced −12% |
| ZBIO Zenas BioPharma, Inc. | 502,077 | $12.7M | 0.74% | Unchanged |
| OMER Omeros Corporation | 847,206 | $11.4M | 0.66% | Added +18% |
| COGT Cogent Biosciences, Inc. | 389,363 | $10.5M | 0.61% | Reduced −25% |
| GPCR Structure Therapeutics Inc. | 640,317 | $10.5M | 0.61% | Unchanged |
| CYTK Cytokinetics, Incorporated | 201,839 | $10.4M | 0.61% | Added +7% |
| SYK Stryker Corporation | 32,300 | $10.2M | 0.59% | Added +11% |
| TNGX Tango Therapeutics, Inc. | 460,031 | $10.1M | 0.59% | Added +1% |
| PTCT PTC Therapeutics, Inc. | 166,548 | $9.6M | 0.56% | Added +3% |
| EVH Evolent Health, Inc. | 2,380,000 | $9.4M | 0.55% | Reduced −5% |
| VERA Vera Therapeutics, Inc. | 356,206 | $9.1M | 0.53% | Reduced −17% |
| AZTA Azenta, Inc. | 202,750 | $9.0M | 0.52% | Reduced −50% |
| PHR Phreesia, Inc. | 748,500 | $8.8M | 0.51% | Added +7% |
| LTGO Latigo Biotherapeutics, Inc. | 654,497 | $8.5M | 0.49% | New |
| CAI Caris Life Sciences, Inc. | 438,500 | $7.8M | 0.45% | Reduced −10% |
| SUPN Supernus, Inc. | 256,500 | $7.5M | 0.44% | Added +4% |
| SMMT Summit Therapeutics Inc. | 715,000 | $7.2M | 0.42% | Unchanged |
| ARDX Ardelyx, Inc. | 2,369,869 | $7.2M | 0.42% | Added +6% |
| TMO Thermo Fisher Scientific Inc. | 10,000 | $6.8M | 0.39% | Unchanged |
| MLYS Mineralys Therapeutics, Inc. | 484,951 | $6.8M | 0.39% | Unchanged |
| FRNM Freenome, Inc. | 677,220 | $6.4M | 0.37% | New |
| IMNM Immunome, Inc. | 367,354 | $5.9M | 0.34% | Added +6% |
| ALNY Alnylam Pharmaceuticals, Inc. | 38,000 | $5.7M | 0.33% | Reduced −43% |
| SYRE Spyre Therapeutics, Inc. | 57,546 | $5.4M | 0.32% | Added +36% |
| MOBI Mobia Medical, Inc. | 418,200 | $5.1M | 0.30% | Unchanged |
| BCAX Bicara Therapeutics Inc. | 535,286 | $4.7M | 0.28% | Unchanged |
| CORT Corcept Therapeutics Incorporated | 72,000 | $4.6M | 0.27% | Unchanged |
| DFTX Definium Therapeutics, Inc. | 154,188 | $4.5M | 0.26% | Added +8% |
| NVO Novo Nordisk A/S | 110,800 | $4.3M | 0.25% | Added +74% |
| FOCL EDAP TMS S.A. | 1,450,000 | $3.9M | 0.22% | Added +5% |
| JANX Janux Therapeutics, Inc. | 367,009 | $3.8M | 0.22% | Unchanged |
| TRVI Trevi Therapeutics, Inc. | 260,000 | $3.5M | 0.20% | Unchanged |
| NGNE Neurogene Inc. | 154,401 | $3.5M | 0.20% | Added +45% |
| PCVX Vaxcyte, Inc. | 60,250 | $3.4M | 0.20% | Unchanged |
| OMDA Omada Health, Inc. | 260,250 | $3.1M | 0.18% | Reduced −30% |
| SGMT Sagimet Biosciences Inc. | 315,458 | $2.8M | 0.17% | Added +26% |
| ABCL AbCellera Biologics Inc. | 275,000 | $2.7M | 0.16% | New |
| OLMA Olema Oncology, Inc. | 383,578 | $2.7M | 0.16% | Added +63% |
| TLPH Talphera, Inc. | 3,589,186 | $2.6M | 0.15% | Unchanged |
| ATEC Alphatec Holdings, Inc. | 360,900 | $2.4M | 0.14% | Added +0% |
| CMPX Compass Therapeutics, Inc. | 3,524,929 | $2.4M | 0.14% | Unchanged |
| NGEN NervGen Pharma Corp. | 1,208,231 | $2.3M | 0.13% | Unchanged |
| IMVT Immunovant, Inc. | 70,103 | $2.2M | 0.13% | New |
| OCUL Ocular Therapeutix, Inc. | 383,716 | $2.2M | 0.13% | Unchanged |
| CVS CVS Health Corporation | 25,500 | $2.1M | 0.12% | Reduced −36% |
| RCUS Arcus Biosciences, Inc. | 114,654 | $1.8M | 0.11% | Reduced −36% |
| IONS Ionis Pharmaceuticals, Inc. | 65,500 | $1.8M | 0.11% | New |
| AVIR Atea Pharmaceuticals, Inc. | 433,620 | $1.7M | <0.1% | New |
| IPSC Century Therapeutics, Inc. | 1,304,347 | $1.6M | <0.1% | Unchanged |
| CELC Celcuity Inc. | 25,513 | $1.4M | <0.1% | New |
| HUM Humana Inc. | 3,350 | $1.3M | <0.1% | New |
| BRVE Braveheart Bio, Inc. | 60,837 | $1.2M | <0.1% | New |
| CLYM Climb Bio Inc | 116,461 | $1.1M | <0.1% | New |
| LENZ LENZ Therapeutics, Inc. | 257,460 | $780K | <0.1% | Unchanged |
| KLRA Kailera Therapeutics, Inc. | 65,000 | $743K | <0.1% | Unchanged |
| AXSM Axsome Therapeutics, Inc. | 5,500 | $721K | <0.1% | Unchanged |
| CAPR Capricor Therapeutics, Inc. | 87,007 | $680K | <0.1% | Added +17% |
| LEGN Legend Biotech Corporation | 33,500 | $515K | <0.1% | Unchanged |
| SION Sionna Therapeutics, Inc. | 99,429 | $285K | <0.1% | Unchanged |
| CMPS COMPASS Pathways plc | 23,778 | $192K | <0.1% | New |
| BCRX BioCryst Pharmaceuticals, Inc. | 22,124 | $161K | <0.1% | Unchanged |
| EYPT EyePoint, Inc. | 329,170 | $80K | <0.1% | Added +23% |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| SGRY Surgery Partners, Inc. | 84,000 | $2.3M |
| DNTH Dianthus Therapeutics, Inc. | 20,326 | $1.7M |
| ORKA Oruka Therapeutics, Inc. | 12,051 | $1.1M |
| GKOS Glaukos Corporation | 4,750 | $1.1M |
| ALT Altimmune, Inc. | 471,465 | $644K |
| VKTX Viking Therapeutics, Inc. | 25,500 | $641K |
| MLTX MoonLake Immunotherapeutics | 10,696 | $117K |